Literature DB >> 16787276

K(v)7 channels: function, pharmacology and channel modulators.

William Dalby-Brown1, Henrik H Hansen, Mads P G Korsgaard, Naheed Mirza, Søren-P Olesen.   

Abstract

K(v)7 channels are unique among K(+) channels, since four out of the five channel subtypes have well-documented roles in the development of human diseases. They have distinct physiological functions in the heart and in the nervous system, which can be ascribed to their voltage-gating properties. The K(v)7 channels also lend themselves to pharmacological modulation, and synthetic openers as well as blockers of the channels, regulating neuronal excitability, have existed even before the K(v)7 channels were identified by cloning. In the present review we give an account on the focused efforts to develop selective modulators, openers as well as blockers, of the K(v)7 channel subtypes, which have been undertaken during recent years, along with a discussion of the K(v)7 ion channel physiology and therapeutic indications for modulators of the neuronal K(v)7 channels.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16787276     DOI: 10.2174/156802606777323728

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  21 in total

1.  Expression and function of the K+ channel KCNQ genes in human arteries.

Authors:  Fu Liang Ng; Alison J Davis; Thomas A Jepps; Maksym I Harhun; Shuk Yin Yeung; Andrew Wan; Marcus Reddy; David Melville; Antonio Nardi; Teck K Khong; Iain A Greenwood
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

2.  Vascular KCNQ channels in humans: the sub-threshold brake that regulates vascular tone?

Authors:  Bharath K Mani; Kenneth L Byron
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

3.  Inactivation as a new regulatory mechanism for neuronal Kv7 channels.

Authors:  Henrik Sindal Jensen; Morten Grunnet; Søren-Peter Olesen
Journal:  Biophys J       Date:  2007-01-19       Impact factor: 4.033

4.  Oxidative modification of M-type K(+) channels as a mechanism of cytoprotective neuronal silencing.

Authors:  Nikita Gamper; Oleg Zaika; Yang Li; Pamela Martin; Ciria C Hernandez; Michael R Perez; Andrew Y C Wang; David B Jaffe; Mark S Shapiro
Journal:  EMBO J       Date:  2006-10-05       Impact factor: 11.598

Review 5.  Kv7 channels: interaction with dopaminergic and serotonergic neurotransmission in the CNS.

Authors:  Henrik H Hansen; Olivier Waroux; Vincent Seutin; Thomas J Jentsch; Susana Aznar; Jens D Mikkelsen
Journal:  J Physiol       Date:  2008-01-03       Impact factor: 5.182

Review 6.  K+ channel modulators for the treatment of neurological disorders and autoimmune diseases.

Authors:  Heike Wulff; Boris S Zhorov
Journal:  Chem Rev       Date:  2008-05       Impact factor: 60.622

7.  Kv7 channels in the nucleus accumbens are altered by chronic drinking and are targets for reducing alcohol consumption.

Authors:  Natalie S McGuier; William C Griffin; Justin T Gass; Audrey E Padula; Elissa J Chesler; Patrick J Mulholland
Journal:  Addict Biol       Date:  2015-06-23       Impact factor: 4.280

8.  Sequence determinants of subtype-specific actions of KCNQ channel openers.

Authors:  Alice W Wang; Runying Yang; Harley T Kurata
Journal:  J Physiol       Date:  2016-09-23       Impact factor: 5.182

Review 9.  New molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channels.

Authors:  Michael A Rogawski; Carl W Bazil
Journal:  Curr Neurol Neurosci Rep       Date:  2008-07       Impact factor: 5.081

10.  Enhancing m currents: a way out for neuropathic pain?

Authors:  Ivan Rivera-Arconada; Carolina Roza; Jose A Lopez-Garcia
Journal:  Front Mol Neurosci       Date:  2009-08-04       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.